2009.10.29 Weekly Broadcast Email

 The following updates were made to the website for the week of October 26, 2009.
________________________________________
91105: Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients
Appendices 12, 13 and 14, Cognitive Testing Booklets, were updated in the most recent amendment (8). The “Old Booklets” from a previous amendment will remain posted in CCRBIS for 90 days after amendment 8 was released. This will allow sites time to have the appendices approved by their IRBs if required.
________________________________________
New Site: Iowa Oncology Research Association
Please join me in welcoming our newest CCOP, Iowa Oncology Research Association, to the WFU CCOP Research Base. We look forward to working with IORA.
________________________________________
Reminder:
97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 9 minority accrual slots open for patient accruals. We would like to see this study close by the end of the year, so if you have patients that may be eligible for this study, please try and get them registered by then.

Thank you,

Lisa Hawkins
Wake Forest University Baptist Medical Center
Department of Radiation Oncology
Research Base Protocol Information Office
2000 West First Street, Suite 401
Winston-Salem, NC 27104
Phone: 336-716-0891
Pager: 336-716-2440, ID number 1689
Fax: 336-716-6275

Quick Reference

Research Base

Fax 336-716-6275
Phone 336-716-0891

2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 11-02-2009
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.